로고

INTRODUCTION

MEMBERS

RESEARCH

BOARD

RESEARCH

Pharmaceutical Economics,
Big Data Analysis & Policy Lab

Conference presentations

Total 160건 9 페이지

2018
40

"Cost-effectiveness of cabozantinib for patients with advanced renal cell carcinoma after failure of prior Therapy in South Korea" Kim S, Han S, Kim H, and Suh HS , The International Society for Pharmacoeconomics and Outcomes Research 21st Annual European Congress Barcelona, Spain. November 2018.
39

"Cost-effectiveness analysis of reslizumab for patients with severe eosinophilic asthma inadequately controlled with high-dose inhaled corticosteroids and long-acting β2-agonists in South Korea" Han S, Kim S, Kim H, and Suh HS , The International Society for Pharmacoeconomics and Outcomes Research 21st Annual European Congress Barcelona, Spain. November 2018.
38

"The impact of Ministry of Food and Drug Safety (MFDS) safety notice on The use of metoclopramide in Korea: a population-based study with an interrupted time series analysis" Kim H, Kim S, Han S, and Suh HS , The International Society for Pharmacoeconomics and Outcomes Research 21st Annual European Congress Barcelona, Spain. November 2018.
37

"Treatment patterns and clinical characteristics among non-valvular atrial fibrillation patients prescribed oral anticoagulants: a nationwide population-based study in Korea" Lee M , Han S, Bang O, On Y, Jang S, Han S, Won M, Park Y, Shin J, Kang S, Suh HS, and Kim Y , The 2018 American Heart Association Scientific Sessions Chicago, USA. November 2018
36

"Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation: A Nationwide Population-Based Study in Korea" Han S, Bang O, On Y, Lee M, Jang S, Han S, Won M, Park Y, Shin J, Kang S, Suh HS, and Kim Y , The 11th Asia Pacific Heart Rhythm Society Scientific Session Taipei, Taiwan. October 2018.
35

"Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban versus Warfarin in Non-Valvular Atrial Fibrillation: A Nationwide Population-Based Study in Korea" Bang O, On Y, Lee M, Jang S, Han S, Han S, Won M, Park Y, Shin J, Kang S, Suh HS, and Kim Y , The 11th Asia Pacific Heart Rhythm Society Scientific Session Taipei, Taiwan. October 2018.
34

"Cost-effectiveness of Dangguijagyag-san for treating primary dysmenorrhea: Study protocol of a multicenter randomized controlled trial" Kim S, Park KS, Lee JM, and Suh HS , The 2018 Fall International Convention of The Pharmaceutical Society of Korea Seoul, Korea. October 2018.
33

"Use of Traditional Medicines for cough and common colds in Korea" Kim H, Choi YJ, and Suh HS , The 2018 Fall International Convention of The Pharmaceutical Society of Korea Seoul, Korea. October 2018.
32

"Association between parkinsonism and The use of propulsives and antipsychotics: case-crossover study" Kim E, Kim S, Han S, Kim H, and Suh HS , The 2018 Fall International Convention of The Pharmaceutical Society of Korea Seoul, Korea. October 2018.
31

"Value of Innovative Medications from The Patients’ Perspective in Asia" Goto R, Suh HS, Pwu JRF, and Liu GG , Workshop 11, The 8th International Society for Pharmacoeconomics and Outcomes Research Asia-Pacific Conference Tokyo, Japan. September 2018.
30

"Occurrence of infections associated with long-term add-on Therapy of oral corticosteroids in elderly patients with severe asthma: A retrospective cohort study" Han S, Son JS, Kim H, Kim S, and Suh HS , The 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management Prague, Czech Republic. August 2018.
29

"Economic burden in patients with primary dysmenorrhea: A cross-sectional survey" Han S, Park KS, Suh HS, and Lee JM. , The 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management Prague, Czech Republic. August 2018.
28

"Disease burden of patients with advanced renal cell carcinoma in Korea" Han S, Kim S, and Suh HS , The 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management Prague, Czech Republic. August 2018.
27

"Low-density Lipoprotein Cholesterol Goal Attainment based on 2015 Korean dyslipidemia guidelines" Kim EJ, Han S, Rane P, Qian Y, Zhao Z, and Suh HS , The 23rd International Society for Pharmacoeconomics and Outcomes Research Annual Meeting Baltimore, USA. May 2018.
26

"Healthcare utilization and disease costs in exudative age-related macular degeneration using National Health Insurance" Kim S, Byun SJ, Suh HS, and Park SJ , The 119th Conference of The Korean Ophthalmological Society Busan, Korea. April 2018.

검색